RCKT - Rocket Pharma gains as Cantor sees $65 price target
2023-10-24 14:17:52 ET
More on Rocket Pharmaceuticals
- Rocket Pharmaceuticals: Update On RP-A501 Strengthens Bullish Outlook
- Rocket Pharmaceuticals: Soaring On Pivotal Danon Disease Study Agreement - More Upside Ahead?
- Rocket Pharmaceuticals: Thriving Gene Therapy With Multiple Catalysts
- Rocket Pharma nabs FDA priority review for gene therapy
- Biggest stock movers today: Grab Holdings, Workhorse Group, Rocket Pharmaceuticals and more
For further details see:
Rocket Pharma gains as Cantor sees $65 price target